https://sputnikglobe.com/20211103/who-approves-emergency-use-of-indias-covaxin-vaccine-1090445016.html

WHO Approves Emergency Use of India's COVAXIN Vaccine

Sputnik International

The medication was developed by the Indian company Bharat Biotech in collaboration with the National Institute of Virology in Pune. 03.11.2021, Sputnik International

2021-11-03T12:21+0000

2022-07-19T10:40+0000

world health organization (who)

coronavirus

https://cdn1.img.sputnikglobe.com/img/07e5/04/04/1082537116_0:0:2621:1475_1920x0_80_0_0_51540d3ea37bcaae86602f82ebf537a0.jpg

The World Health Organisation has granted permission for the emergency use of COVAXIN, an official statement issued on Wednesday read.Aside from COVAXIN, the organisation has so far certified six vaccines - Pfizer/BioNTech's drug, AstraZeneca's Covishield, Johnson & Johnson's vaccine, Moderna's mRNA-1273, Sinopharm's BBIBP-CorV, and Sinovac's CoronaVac.

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

2021

Evgeny Mikhaylov

https://cdn1.img.sputnikglobe.com/img/07e4/09/07/1080390164_0:0:1440:1440_100x100_80_0_0_46c187f2ab0908f86849a7d09a7def57.jpg

Evgeny Mikhaylov

https://cdn1.img.sputnikglobe.com/img/07e4/09/07/1080390164_0:0:1440:1440_100x100_80_0_0_46c187f2ab0908f86849a7d09a7def57.jpg

News

en_EN

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

1920

1080

true

1920

1440

true

https://cdn1.img.sputnikglobe.com/img/07e5/04/04/1082537116_68:0:2397:1747_1920x0_80_0_0_e0fd525cf8829dd20fa7f6d84f16cb68.jpg

1920

true

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

Evgeny Mikhaylov

https://cdn1.img.sputnikglobe.com/img/07e4/09/07/1080390164_0:0:1440:1440_100x100_80_0_0_46c187f2ab0908f86849a7d09a7def57.jpg

world health organization (who), coronavirus

WHO Approves Emergency Use of India's COVAXIN Vaccine

12:21 GMT 03.11.2021 (Updated: 10:40 GMT 19.07.2022)

© REUTERS / ADNAN ABIDIFILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo/File Photo

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo/File Photo - Sputnik International, 1920, 03.11.2021

Evgeny Mikhaylov

All materials Write to the author

The medication was developed by the Indian company Bharat Biotech in collaboration with the National Institute of Virology in Pune.

The World Health Organisation has granted permission for the emergency use of COVAXIN, an official statement issued on Wednesday read.

"The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs [the] risks & the vaccine can be used", the WHO said.

🆕 WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19. pic.twitter.com/dp2A1knGtT
— World Health Organization (WHO) (@WHO) November 3, 2021

Aside from COVAXIN, the organisation has so far certified six vaccines - Pfizer/BioNTech's drug, AstraZeneca's Covishield, Johnson & Johnson's vaccine, Moderna's mRNA-1273, Sinopharm's BBIBP-CorV, and Sinovac's CoronaVac.